Rankings
▼
Calendar
EOLS FY 2020 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena
EOLS
Evolus, Inc.
$353M
FY 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$57M
+61.9% YoY
Gross Profit
$38M
67.6% margin
Operating Income
-$153M
-270.7% margin
Net Income
-$163M
-288.3% margin
EPS (Diluted)
$-4.83
Cash Flow
Operating Cash Flow
-$58M
Free Cash Flow
-$61M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$209M
Total Liabilities
$282M
Stockholders' Equity
-$73M
Cash & Equivalents
$103M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$57M
$35M
+61.9%
Gross Profit
$38M
$27M
+42.1%
Operating Income
-$153M
-$99M
-54.7%
Net Income
-$163M
-$90M
-81.1%
← Q4 2019
All Quarters
Q1 2020 →